# Immunogenicity of After Primary Immunization and Booster Immunization of sIPV

> **NCT06058429** · — · UNKNOWN · sponsor: **Sinovac Biotech Co., Ltd** · enrollment: 233 (actual)

## Conditions studied

- Polio

## Interventions

- **OTHER:** no intervention

## Key facts

- **NCT ID:** NCT06058429
- **Lead sponsor:** Sinovac Biotech Co., Ltd
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** UNKNOWN
- **Start date:** 2023-08-16
- **Primary completion:** 2023-09-07
- **Final completion:** 2023-12-31
- **Target enrollment:** 233 (ACTUAL)
- **Last updated:** 2023-10-26

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06058429

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06058429, "Immunogenicity of After Primary Immunization and Booster Immunization of sIPV". Retrieved via AI Analytics 2026-06-08 from https://api.ai-analytics.org/clinical/NCT06058429. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*